EFTA00015972.pdf
- Type
- pdf
- Source set
- data-set-8
Original source
Extracted text
From:
To:
(US %NYS)"
Cc:
(USANYS)"
USANYS •
SANYS
USANYS
[=.
SANYS
USANYS)"
USANYS
USANYS)"
(USANYS) 1"
SANYS
Subject: RE: Disparities in Counsel and Discovery Access for Ghislaine Maxwell and Justin Rivera
Date: Mon, 21 Dec 2020 21:55:26 +0000
Yes, I highlighted the huge volume of discovery for Maxwell when I spoke with
this morning. That volume was a
significant driver in our team's decision to request that she receive so much time to review her discovery. Based on my
read of the transcript from this morning's Rivera conference, it sounds like Rivera is not even using all the time he has
now. By contrast, my understanding is that Maxwell is using up the full time she has been given.
From:
(USANYS)
Sent: Monday, December 21, 2020 4:47 PM
To:
(USANYS)
(USANYS)
(USANYS)
(USANYS)
Cc:
>;
(USANYS)
(USANYS)
(USANYS)
(USANYS)
);
(USANYS) 1
(USANYS)
Subject: RE: Disparities in Counsel and Discovery Access for Ghislaine Maxwell and Justin Rivera
I'd also look into potential differences in the volume of discovery. No idea what your case entails, MEI but in Maxwell
we have produced truly enormous volumes of material (we seized 60 some devices during the investigation, for example,
in addition to an entire FBI file from the prior Florida investigation...) that may explain some of this.
From:
(USANYS)
Sent: Monday, December 21, 2020 4:42 PM
To:
(USANYS)<
(USANYS)
(USANYS) <
(USANYS)
•
<
(USANYS)
Cc:
4
4
>
(USANYS) <
(USANYS)
(USANYS)
(USANYS)
(USANYS) 1
Subject: RE: Disparities in Counsel and Discovery Access for Ghislaine Maxwell and Justin Rivera
Thanks,
Can you keep me posted on what we think will be the substance of the draft declaration when you know
(that is, before we are submitting anything on 12/31)? And how much of this is attributable to differences between MCC
and MDC, as well as specific differences in their housing situations?
From:
(USANYS).ca
Sent: Monday, December 21, 2020 4:35 PM
EFTA00015972…
Open in the interactive archive →